Moreover, metformin can induce AMPK-dependent metabolic regulation of T cells in TIME, thereby enhancing their activity and increasing the quantity and force of TM, thereby enhancing genetic immunity and tolerance, and thereby increasing the response and efficiency of tumor immunotherapy [118]. The gene discussed is PRKAA1; the disease is neoplasm.